|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities | |||||
| Deferred tax provision | |||||
| Contingent consideration | |||||
| Depreciation | |||||
| Impairment of property, plant and equipment | |||||
| Share-based compensation expense | |||||
| Finance lease amortization | |||||
| Deferred financing fee write-off | |||||
| Amortization of right-of-use assets | |||||
| Changes in operating assets and liabilities | |||||
| Other current assets | |||||
| Prepaid expenses | |||||
| Security deposits | |||||
| Accounts payable | |||||
| Accrued liabilities and other | |||||
| Accrued liabilities | |||||
| Operating lease liabilities | |||||
| Income taxes payable | |||||
| Other changes in operating assets and liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Additions to property, plant and equipment | |||||
| Reimbursement of capital expenditures | |||||
| Reimbursements of development costs in accordance with the JDA | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Issuance of Class A common stock to Cottonmouth | |||||
| Cash received from Trust | |||||
| BCF Holdings capital repayment | |||||
| Repayments of notes payable - insurance premium financing | |||||
| Repayments of the principal portion of finance lease liabilities | |||||
| Warrant exercises | |||||
| Deferred financing costs | |||||
| Payment of equity issuance costs | |||||
| Net cash provided by financing activities | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, beginning of the period | |||||
| Cash, beginning of the period | |||||
| Cash, end of the period | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| CENAQ operating cash balance acquired | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental cash flows: | |||||
| Non-cash income tax payable and deferred tax liability obtained from CENAQ | |||||
| Non-cash impact of debt issuance through the business combination | |||||
| Capital expenditures in accounts payable and accrued expenses (at period end) | |||||
| Cash paid for interest | |||||
| Capital expenditures in accounts payable and accrued liabilities (at period end) | |||||
| Accounts receivable for reimbursement of capital expenditures (at period end) | |||||
| Cash paid for income taxes | |||||
Loading...